BACKGROUND AND AIMS: It is recognized that overt thyroid dysfunction is associated with weight changes, but the influence of a minor alteration of thyroid function remains unclear. This study aimed to further investigate the relationship between obesity and thyroid function and to examine the possible role of insulin resistance on the hypothalamic-pituitary- thyroid axis. METHODS AND RESULTS: Serum TSH and free T4 (FT4) levels, anthropometric and metabolic parameters were evaluated in 581 obese patients. In all patients TSH values progressively increased according to the severity of obesity and were positively correlated with body mass index (p=0.001, r=0.13) and waist circumference (p=0.02, r=0.11). Patients with insulin resistance showed higher TSH (1.8±1.0 vs 1.6±0.9 μUI/l; p=0.03) and lower FT4 levels (13.8±2.3 vs 15.0±2.2 pmol/l; p<0.001), as compared with patients with normal insulin sensitivity. Moreover, TSH was positively correlated with fasting insulin (p<0.001, r=0.152) and homeostasis model assessment of insulin resistance (HOMA-IR; p<0.001, r=0.148), and negatively correlated with Quantitative Insulin Sensitivity Check Index (QUICKI; p<0.001, r=-0.148); FT4 was negatively associated with fasting insulin (p<0.001, r=-0.287) and HOMA-IR (p<0.001, r=-0.295), and positively associated with QUICKI (p<0.001, r=0.295). CONCLUSIONS: A relationship between thyroid function and overweight/ obesity condition seems to exist, mainly influenced by insulin resistance. Whether variations in TSH and/or thyroid hormones, within a normal range, can influence body weight or whether obesity per se can alter thyroid function cannot be stated so far. Further studies are needed to assess the link between thyroid function and body weight, by considering not only changes in thyroid hormones, but also body fat distribution, obesity duration and low-grade inflammation.
BACKGROUND AND AIMS: It is recognized that overt thyroid dysfunction is associated with weight changes, but the influence of a minor alteration of thyroid function remains unclear. This study aimed to further investigate the relationship between obesity and thyroid function and to examine the possible role of insulin resistance on the hypothalamic-pituitary- thyroid axis. METHODS AND RESULTS: Serum TSH and free T4 (FT4) levels, anthropometric and metabolic parameters were evaluated in 581 obesepatients. In all patientsTSH values progressively increased according to the severity of obesity and were positively correlated with body mass index (p=0.001, r=0.13) and waist circumference (p=0.02, r=0.11). Patients with insulin resistance showed higher TSH (1.8±1.0 vs 1.6±0.9 μUI/l; p=0.03) and lower FT4 levels (13.8±2.3 vs 15.0±2.2 pmol/l; p<0.001), as compared with patients with normal insulin sensitivity. Moreover, TSH was positively correlated with fasting insulin (p<0.001, r=0.152) and homeostasis model assessment of insulin resistance (HOMA-IR; p<0.001, r=0.148), and negatively correlated with Quantitative Insulin Sensitivity Check Index (QUICKI; p<0.001, r=-0.148); FT4 was negatively associated with fasting insulin (p<0.001, r=-0.287) and HOMA-IR (p<0.001, r=-0.295), and positively associated with QUICKI (p<0.001, r=0.295). CONCLUSIONS: A relationship between thyroid function and overweight/ obesity condition seems to exist, mainly influenced by insulin resistance. Whether variations in TSH and/or thyroid hormones, within a normal range, can influence body weight or whether obesity per se can alter thyroid function cannot be stated so far. Further studies are needed to assess the link between thyroid function and body weight, by considering not only changes in thyroid hormones, but also body fat distribution, obesity duration and low-grade inflammation.
Authors: D J Burks; J Font de Mora; M Schubert; D J Withers; M G Myers; H H Towery; S L Altamuro; C L Flint; M F White Journal: Nature Date: 2000-09-21 Impact factor: 49.962
Authors: Annemieke Roos; Stephan J L Bakker; Thera P Links; Rijk O B Gans; Bruce H R Wolffenbuttel Journal: J Clin Endocrinol Metab Date: 2006-11-07 Impact factor: 5.958
Authors: Marina A Michalaki; Apostolos G Vagenakis; Aggeliki S Leonardou; Marianna N Argentou; Ioannis G Habeos; Maria G Makri; Agathoklis I Psyrogiannis; Fotis E Kalfarentzos; Venetsana E Kyriazopoulou Journal: Thyroid Date: 2006-01 Impact factor: 6.568
Authors: Christian S Wright; Amy Craddock; Eileen M Weinheimer-Haus; Eunjung Lim; Travis B Conley; Elsa M Janle; Wayne W Campbell Journal: Endocr Res Date: 2016-01-04 Impact factor: 1.720
Authors: A F Radicioni; N Tahani; M Spaziani; A Anzuini; C Piccheri; A Semeraro; L Tarani; A Lenzi Journal: J Endocrinol Invest Date: 2012-08-29 Impact factor: 4.256
Authors: Margaret C Garin; Alice M Arnold; Jennifer S Lee; Russell P Tracy; Anne R Cappola Journal: J Clin Endocrinol Metab Date: 2014-01-16 Impact factor: 5.958
Authors: James E Haddow; Wendy Y Craig; Glenn E Palomaki; Louis M Neveux; Geralyn Lambert-Messerlian; Jacob A Canick; Fergal D Malone; Mary E D'Alton Journal: Thyroid Date: 2013-02 Impact factor: 6.568
Authors: Manju Mamtani; Hemant Kulkarni; Thomas D Dyer; Laura Almasy; Michael C Mahaney; Ravindranath Duggirala; Anthony G Comuzzie; Paul B Samollow; John Blangero; Joanne E Curran Journal: BMC Endocr Disord Date: 2014-06-10 Impact factor: 2.763